Compare
Medtronic plc vs Conmed Corp vs Stereotaxis, Inc. vs iTonic Holdings Ltd
| Latest fiscal year | Medtronic plc MDT | Conmed Corp CNMD | Stereotaxis, Inc. STXS | iTonic Holdings Ltd ITOC |
|---|---|---|---|---|
| Year ended | 2026-04-24 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $36.36B | $1.37B | $32.38M | $523.0K |
| Revenue growth (YoY) | +8.4% | +5.2% | +20.3% | +16.7% |
| Gross margin | 65.0% (computed) | 54.6% | 52.7% | 62.6% |
| Operating margin | 17.8% | 7.5% | -68.3% | -991.7% |
| Net margin | 13.2% | 3.4% | -66.8% | -974.7% |
| Net income | $4.80B | $47.05M | -$21.64M | -$5.10M |
| EPS (Diluted) | $3.73 | $1.51 | -$0.25 | -$0.32 |
| Operating cash flow | $7.33B | $170.69M | -$13.69M | -$3.23M |
| Free cash flow | $5.43B | $150.88M | -$13.78M | -$3.24M |
| Cash & equivalents | $1.95B | n/a | $13.42M | $1.49M |
| Total assets | $93.03B | $2.33B | $52.25M | $9.10M |
| Total liabilities | $42.96B | $1.29B | $33.53M | $969.8K |
| Shareholders' equity | $49.46B | $1.03B | $13.48M | $6.12M |
| Return on year-end equity | 9.7% | 4.6% | -160.5% | -83.3% |
| Shares outstanding | 1.28B | n/a | n/a | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Medtronic plc | Conmed Corp | Stereotaxis, Inc. | iTonic Holdings Ltd |
|---|---|---|---|---|
| Latest | $36.36B Ended 2026-04-24 | $1.37B Ended 2025-12-31 | $32.38M Ended 2025-12-31 | $523.0K Ended 2025-12-31 |
| 1 year earlier | $33.54B Ended 2025-04-25 | $1.31B Ended 2024-12-31 | $26.92M Ended 2024-12-31 | $448.2K Ended 2024-12-31 |
| 2 years earlier | $32.36B Ended 2024-04-26 | $1.24B Ended 2023-12-31 | $26.77M Ended 2023-12-31 | $628.6K Ended 2023-12-31 |
| 3 years earlier | $31.23B Ended 2023-04-28 | $1.05B Ended 2022-12-31 | $28.15M Ended 2022-12-31 | $679.8K Ended 2022-12-31 |
| 4 years earlier | $31.69B Ended 2022-04-29 | $1.01B Ended 2021-12-31 | $35.02M Ended 2021-12-31 | n/a |